v3.24.3
Condensed Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash Flows From Operating Activities    
Net loss $ (4,895,093) $ (4,535,100)
Adjustments to reconcile net loss:    
Depreciation 184,441 134,408
Change in fair value of marketable securities, available for sale 16,930 (31,426)
Impairment of property & equipment 1,674,000 0
Stock based compensation 651,115 1,015,087
Change of right-of-use asset 67,518 64,869
Gain on sale of R&D assets (50,097) 0
Loss on disposal of property & equipment 172,684 0
Change in inventory reserve 293,058 0
Accounts receivable (125,000) 0
Inventories 139,757 (777,831)
Prepaid expenses and other current assets (6,587) 394,739
Accounts payable (13,753) (60,515)
Accrued liabilities (452,669) (18,869)
Operating lease liabilities (68,532) (63,853)
Contract liabilities - customer deposits 475 500
Net cash used in operating activities (2,411,753) (3,877,991)
Cash Flows From Investing Activities    
Net redemptions (purchase) of marketable securities 3,000,000 (9,841,346)
Realized gain on sale of marketable securities (35,210) (23,747)
Proceeds from disposition of property & equipment 6,000 0
Purchase of property and equipment (2,874,724) (328,534)
Net cash provided by (used in) investing activities 96,066 (10,193,627)
Cash Flows From Financing Activities    
Proceeds from issuance of common stock 0 6,996,015
Deferred offering costs 0 (66,463)
Repayments of finance lease (15,685) (11,844)
Repayments of advances from affiliates (393,969) (755,299)
Advances from affiliates 104,237 580,830
Net cash (used in) provided by financing activities (305,417) 6,743,239
Net change in cash and cash equivalents (2,621,104) (7,328,379)
Cash and cash equivalents at beginning of period 9,821,531 12,767,199
Cash and cash equivalents at end of period 7,200,427 5,438,820
Supplemental Cash Flow Information    
Cash paid for interest 7,362 2,928
Non Cash Investing and Financing Activities    
Right of use asset - finance leases $ 31,572 $ 92,405

Source